Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence.
World J Hepatol
; 13(8): 916-925, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1395151
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has swept through nations, crippled economies and caused millions of deaths worldwide. Many people diagnosed with COVID-19 infections are often found to develop liver injury, which, in a small portion of patients, progresses to severe liver disease. Liver injury in the form of elevated transaminases, hyperbilirubinemia and alterations in serum albumin has been observed to be higher in patients with severe forms of the disease. Those who already have insult to the liver from chronic disease, such as nonalcoholic fatty liver disease (NAFLD) may be at the greatest disadvantage. The severity of COVID-19 also seems to be driven by the presence of NAFLD and other co-morbidities. About 25% of the global population has NAFLD. With such a widespread prevalence of NAFLD, understanding the disease progression of COVID-19 and the occurrence of liver injury in this vulnerable population assumes great significance. In this review, we present an overview of COVID-19 infection in patients with NAFLD.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
/
Revisiones
Idioma:
Inglés
Revista:
World J Hepatol
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Wjh.v13.i8.916
Similares
MEDLINE
...
LILACS
LIS